Results 1 to 10 of about 2,190 (96)

Surgery Versus Perioperative Chemotherapy In Non Metastatic Muscle Invasive Bladder Carcinoma [PDF]

Egyptian Journal of Medical Research, 2022
According to treatment  guidelines of urinary bladder carcinoma, using Neoadjuvent chemotherapy followed by radical cystectomy is the standard treatment which improve overall survival and progression free survival.
Sarah Ali, Mamdouh El Sherbiny, Mohamed Aly El- Wakil, Ahmed Shaban   +3 more
doaj   +1 more source

Predictors of response to BCG therapy in non-muscle invasive bladder cancer [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2022
Intravesical BCG (Bacillus Calmette–Guerin) therapy represents the therapy of choice for intermediaryand high-risk non-muscle invasive bladder cancers after transurethral resection.
Radovanović Milan, Petrović Miloš, Šantrić Veljko, Zubelić Aleksa   +3 more
doaj   +1 more source

Treatment trends of muscle invasive bladder cancer: Evidence from the Surveillance, Epidemiology, and End Results database, 1988 to 2013

Asian Journal of Urology, 2023
Objective: Guidelines for muscle-invasive bladder cancer (MIBC) recommend that patients receive neoadjuvant chemotherapy with radical cystectomy as treatment over radical cystectomy alone.
Victor Chalfant, Michael L. Blute, Jr., Peter Silberstein   +2 more
doaj   +1 more source

Dynamic changes of quality of life in muscle-invasive bladder cancer survivors

BMC Urology, 2022
Background To explore the dynamic changes and effects of radical cystectomy on quality of life in muscle-invasive bladder cancer survivors. Methods Patients with muscle-invasive bladder cancer were randomly recruited in this study.
Yuh-Shyan Tsai, Tzu-Yi Wu, Chien-Hui Ou, Hong-Lin Cheng, Tzong-Shin Tzai, Wen-Horng Yang, Jung-Der Wang   +6 more
doaj   +1 more source

Impact of Diagnosing Urologists and Hospitals on the Use of Radical Cystectomy

European Urology Open Science, 2020
Background: One out of five patients with muscle-invasive bladder cancer undergo radical cystectomy—a guideline-recommended treatment. Previous studies have primarily evaluated patient characteristics associated with the use of radical cystectomy ...
Vishnukamal Golla, Yong Shan, Hemalkumar B. Mehta, Zachary Klaassen, Douglas S. Tyler, Jacques Baillargeon, Ashish M. Kamat, Stephen J. Freedland, John L. Gore, Karim Chamie, Yong-Fang Kuo, Stephen B. Williams   +11 more
doaj   +1 more source

RAZOR trial: analysis of 3-year follow-up: an era of robotic radical cystectomy: is it a new beginning?

African Journal of Urology, 2021
RAZOR (Randomized Open versus Robotic Cystectomy) trial is a phase 3 randomized control trial comparing robot-assisted laparoscopic radical cystectomy with open radical cystectomy for the treatment of bladder cancer published by Parekh et.al.
Satish Kumar Ranjan
doaj   +1 more source

Randomized Controlled Trial of Laparoscopic versus Open Radical Cystectomy in a Laparoscopic Naïve Center

Advances in Urology, 2021
Background. Laparoscopic radical cystectomy is a challenging surgical procedure; however, it has been largely abandoned in favor of the more intuitive robotic-assisted cystectomy.
Waleed Mohamed Fadlalla, Ayman Hanafy, Mahmoud Abdelhakim, Hatem Aboulkassem, El Sayed Ashraf, Ahmed Abdelbary   +5 more
doaj   +1 more source

Mortality after radical cystectomy is strongly related to the institution's volume of surgeries

Einstein (São Paulo), 2020
Objective: To analyze mortality rates and hospitalization data after radical cystectomy in each public healthcare center in São Paulo in the last decade, considering the number of surgeries performed at each center. Methods: This study included patients
Fernando Korkes, Frederico Timóteo Silva Cunha, Matheus Prado Nascimento, Antonio Flávio Silva Rodrigues, Willy Baccaglini, Sidney Glina   +5 more
doaj   +2 more sources

Robot-Assisted and Open Radical Cystectomy: Comparative Analysis of Results

Вестник урологии, 2020
Radical cystectomy (RC) remains the main method of surgical treatment of patients with muscle-invasive bladder cancer. Currently, in case of radical cystectomy, along with the open, robot-assisted access is actively used. This review presents an analysis
B. G. Guliev, R. R. Bolokotov
doaj   +1 more source

Is TURBT able to cure high risk recurrent superficial or muscle invasive bladder cancer: Factors resulting in pT0 radical cystectomy specimens

International Brazilian Journal of Urology, 2013
Purpose In 76% of radical cystectomy patients there is discrepancy between the initial stage at transurethral resection and the final pathological stage of the cystectomy specimen.
Evangelos Mazaris, Shady Nafie, Gregory Boustead   +2 more
doaj   +1 more source